{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:43:03Z","timestamp":1791528183650,"version":"4.3.4"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["1U01AI151758"],"award-info":[{"award-number":["1U01AI151758"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["AI175134"],"award-info":[{"award-number":["AI175134"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["AI137276"],"award-info":[{"award-number":["AI137276"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["RO1AI158569"],"award-info":[{"award-number":["RO1AI158569"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["311543\/Z\/24\/Z"],"award-info":[{"award-number":["311543\/Z\/24\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","award":["PTR-212-19"],"award-info":[{"award-number":["PTR-212-19"]}],"id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"EC | HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","award":["101137033"],"award-info":[{"award-number":["101137033"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"name":"German Centre for International Migration and Development"},{"name":"Department of Defense (DoD) office of the Congressionally Directed Medical Research Programs (CDMRP)\/Peer Reviewed Medical Research Program (PRMRP), Catalyst and Transformational Awards from Dr. Ralph","award":["W81XWH1910235"],"award-info":[{"award-number":["W81XWH1910235"]}]},{"name":"the Chan Zuckerberg Biohub"},{"name":"DoD office of the CDMRP\/PRMRP","award":["W81XWH2210283"],"award-info":[{"award-number":["W81XWH2210283"]}]},{"name":"Defense Threat Reduction Fundamental Research to Counter Weapons of Mass Destruction","award":["HDTRA11810039"],"award-info":[{"award-number":["HDTRA11810039"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Our understanding of a protective humoral immune response to dengue virus (DENV) remains limited. The envelope (E) protein is the main antibody (Ab) target. While anti-fusion loop (FL) epitope monoclonal Abs (mAbs) can induce antibody dependent enhancement (ADE) in vitro, some mAbs targeting quaternary epitopes can cross-neutralize different DENV serotypes. However, the contribution of each Ab subset to disease outcome remains poorly characterized. We defined DENV2 E epitope-specific Abs dynamics and assessed their association with disease outcome in a cohort of hospitalized and subclinical dengue patients during post-primary DENV2 infection. We quantified and isolated anti-E epitope-specific Abs and tested their enhancing and neutralizing capacity. During the critical phase, FL-targeting antibodies were increased in hospitalized patients compared to subclinical cases. Antibodies targeting quaternary epitopes were reduced in severe dengue compared to classical dengue fever patients. Functionally, quaternary epitope-targeting antibodies showed stronger neutralization and cross-neutralization properties, while FL-binding antibodies displayed stronger in vitro enhancement. These findings show that anti-DENV2 E epitope-specific Ab proportions correlate with disease susceptibility and severity, with important implications for novel vaccine design.<\/jats:p>","DOI":"10.1038\/s44321-026-00485-7","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T14:48:21Z","timestamp":1786027701000},"page":"3448-3473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dengue virus envelope epitope-specific antibodies are associated with protection from severe dengue"],"prefix":"10.1038","volume":"18","author":[{"given":"Sokchea","family":"Lay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4717-7618","authenticated-orcid":false,"given":"Heidi","family":"Auerswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8341-1209","authenticated-orcid":false,"given":"Sievleang","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sopheak","family":"Sorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreymom","family":"Ken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Esteban","family":"Rebell\u00f3n Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Vinueza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Angel","family":"Villar Centeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirit","family":"Einav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anavaj","family":"Sakuntabhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9953-7988","authenticated-orcid":false,"given":"Felix A","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin K","family":"Ari\u00ebn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sowath","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veasna","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Barba-Spaeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8911-1502","authenticated-orcid":false,"given":"Tineke","family":"Cantaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"485_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2025.102841","volume":"65","author":"E Abbasi","year":"2025","unstructured":"Abbasi E (2025) The impact of climate change on travel-related vector-borne diseases: a case study on dengue virus transmission. Travel Med Infect Dis 65:102841","journal-title":"Travel Med Infect Dis"},{"key":"485_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-31332-3","volume":"16","author":"S Ahmed","year":"2025","unstructured":"Ahmed S, Schaduangrat N, Pipattanaboon C, Shoombuatong W (2025) Accurate identification of broadly neutralizing antibodies against dengue virus based on deep stacking strategy with multi-perspective features. Sci Rep 16:1720","journal-title":"Sci Rep"},{"key":"485_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2024.199445","volume":"348","author":"JC Balingit","year":"2024","unstructured":"Balingit JC, Denis D, Suzuki R, Hayati RF, Ngwe Tun MM, Takamatsu Y, Masyeni S, Sasmono RT, Morita K (2024) Impact of pre-existing cross-reactive antibodies on cyclic dengue outbreaks in the hyperendemic region of Bali, Indonesia. Virus Res 348:199445","journal-title":"Virus Res"},{"key":"485_CR4","doi-asserted-by":"publisher","first-page":"e1000790","DOI":"10.1371\/journal.ppat.1000790","volume":"6","author":"SJ Balsitis","year":"2010","unstructured":"Balsitis SJ, Williams KL, Lachica R, Flores D, Kyle JL, Mehlhop E, Johnson S, Diamond MS, Beatty PR, Harris E (2010) Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog 6:e1000790","journal-title":"PLoS Pathog"},{"key":"485_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nature18938","volume":"536","author":"G Barba-Spaeth","year":"2016","unstructured":"Barba-Spaeth G, Dejnirattisai W, Rouvinski A, Vaney M-C, Medits I, Sharma A, Simon-Lori\u00e8re E, Sakuntabhai A, Cao-Lormeau V-M, Haouz A, England P, Stiasny K, Mongkolsapaya J, Heinz FX, Screaton GR, Rey FA (2016) Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature 536:48\u201353","journal-title":"Nature"},{"key":"485_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","volume":"8","author":"M Beltramello","year":"2010","unstructured":"Beltramello M, Williams KL, Simmons CP, Macagno A, Simonelli L, Quyen NTH, Sukupolvi-Petty S, Navarro-Sanchez E, Young PR, de Silva AM, Rey FA, Varani L, Whitehead SS, Diamond MS, Harris E, Lanzavecchia A, Sallusto F (2010) The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 8:271\u2013283","journal-title":"Cell Host Microbe"},{"key":"485_CR7","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GRW, Simmons CP, Scott TW, Farrar JJ, Hay SI (2013) The global distribution and burden of dengue. Nature 496:504\u2013507","journal-title":"Nature"},{"key":"485_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44330-8","volume":"15","author":"S Bos","year":"2024","unstructured":"Bos S, Graber AL, Cardona-Ospina JA, Duarte EM, Zambrana JV, Ru\u00edz Salinas JA, Mercado-Hernandez R, Singh T, Katzelnick LC, de Silva A, Kuan G, Balmaseda A, Harris E (2024) Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype. Nat. Commun. 15:382","journal-title":"Nat. Commun."},{"key":"485_CR9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41577-020-00410-0","volume":"20","author":"S Bournazos","year":"2020","unstructured":"Bournazos S, Gupta A, Ravetch JV (2020) The role of IgG Fc receptors in antibody-dependent enhancement. Nat Rev Immunol 20:633\u2013643","journal-title":"Nat Rev Immunol"},{"key":"485_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1099\/vir.0.82537-0","volume":"88","author":"T Chareonsirisuthigul","year":"2007","unstructured":"Chareonsirisuthigul T, Kalayanarooj S, Ubol S (2007) Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. J Gen Virol 88:365\u2013375","journal-title":"J Gen Virol"},{"key":"485_CR11","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.3892\/mmr.2016.5454","volume":"14","author":"J Chen","year":"2016","unstructured":"Chen J, Wen K, Li X-Q, Yi H-S, Ding X-X, Huang Y-F, Pan Y-X, Hu D-M, Di B, Che X-Y, Fu N (2016) Functional properties of DENV EDIII\u2011reactive antibodies in human DENV\u20111\u2011infected sera and rabbit antiserum to EDIII. Mol Med Rep 14:1799\u20131808","journal-title":"Mol Med Rep"},{"key":"485_CR12","doi-asserted-by":"publisher","first-page":"e4991","DOI":"10.1371\/journal.pone.0004991","volume":"4","author":"WD Crill","year":"2009","unstructured":"Crill WD, Hughes HR, Delorey MJ, Chang G-JJ (2009) Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens. PLoS ONE 4:e4991","journal-title":"PLoS ONE"},{"key":"485_CR13","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1126\/science.1185181","volume":"328","author":"W Dejnirattisai","year":"2010","unstructured":"Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, Puttikhunt C, Edwards C, Duangchinda T, Supasa S, Chawansuntati K, Malasit P, Mongkolsapaya J, Screaton G (2010) Cross-reacting antibodies enhance dengue virus infection in humans. Science 328:745\u2013748","journal-title":"Science"},{"key":"485_CR14","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/ni.3515","volume":"17","author":"W Dejnirattisai","year":"2016","unstructured":"Dejnirattisai W, Supasa P, Wongwiwat W, Rouvinski A, Barba-Spaeth G, Duangchinda T, Sakuntabhai A, Cao-Lormeau V-M, Malasit P, Rey FA, Mongkolsapaya J, Screaton GR (2016) Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus. Nat Immunol 17:1102\u20131108","journal-title":"Nat Immunol"},{"key":"485_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ni.3058","volume":"16","author":"W Dejnirattisai","year":"2015","unstructured":"Dejnirattisai W, Wongwiwat W, Supasa S, Zhang X, Dai X, Rouvinski A, Jumnainsong A, Edwards C, Quyen NTH, Duangchinda T, Grimes JM, Tsai W-Y, Lai C-Y, Wang W-K, Malasit P, Farrar J, Simmons CP, Zhou ZH, Rey FA, Mongkolsapaya J, Screaton GR (2015) A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat Immunol 16:170\u2013177","journal-title":"Nat Immunol"},{"key":"485_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102943","volume":"78","author":"J Deng","year":"2024","unstructured":"Deng J, Zhang H, Wang Y, Liu Q, Du M, Yan W, Qin C, Zhang S, Chen W, Zhou L, Liu M, Niu B, Liu J (2024) Global, regional, and national burden of dengue infection in children and adolescents: an analysis of the Global Burden of Disease Study 2021. EClinicalMedicine 78:102943","journal-title":"EClinicalMedicine"},{"key":"485_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115613","volume":"44","author":"AG Dias","year":"2025","unstructured":"Dias AG, Duarte EM, Zambrana JV, Cardona-Ospina JA, Bos S, Roy V, Huffaker J, Kuan G, Balmaseda A, Alter G, Harris E (2025) Anti-dengue virus antibodies that elicit complement-mediated lysis of Zika virion correlate with protection from severe dengue disease. Cell Rep 44:115613","journal-title":"Cell Rep"},{"key":"485_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.aaa8651","volume":"349","author":"G Fibriansah","year":"2015","unstructured":"Fibriansah G, Ibarra KD, Ng T-S, Smith SA, Tan JL, Lim X-N, Ooi JSG, Kostyuchenko VA, Wang J, de Silva AM, Harris E, Crowe JE, Lok S-M (2015) DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers. Science 349:88\u201391","journal-title":"Science"},{"key":"485_CR20","doi-asserted-by":"publisher","first-page":"e01461","DOI":"10.1128\/mBio.01461-15","volume":"6","author":"EN Gallichotte","year":"2015","unstructured":"Gallichotte EN, Widman DG, Yount BL, Wahala WM, Durbin A, Whitehead S, Sariol CA, Crowe JE, de Silva AM, Baric RS (2015) A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies. mBio 6:e01461\u201301415","journal-title":"mBio"},{"key":"485_CR21","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1038\/s41590-023-01654-3","volume":"24","author":"L Ghita","year":"2023","unstructured":"Ghita L, Yao Z, Xie Y, Duran V, Cagirici HB, Samir J, Osman I, S\u00e1nchez DER, Rojas OLA, Sanz AM, Sahoo MK, Robinson ML, Ramirez RMG, Bueno N, Luciani F, Pinsky BA, Montoya JG, Cardenas MIE, Centeno LAV, Garrido EMR, Rosso F, Quake SR, Zanini F, Einav S (2023) Global and cell type-specific immunological hallmarks of severe dengue progression identified via a systems immunology approach. Nat. Immunol. 24:2150\u20132163","journal-title":"Nat. Immunol."},{"key":"485_CR22","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.chom.2025.06.006","volume":"33","author":"G Gonnella","year":"2025","unstructured":"Gonnella G, Libri V, Gioacchino E, Mella S, Sann S, Sorn S, Ken S, Seffer V, Ya N, Heng L, Yay C, Sakuntabhai A, Ly S, Dussart P, Duong V, Hasan M, Cantaert T (2025) Immune profiling in subclinical secondary dengue-infected cases reveals adaptive immune signatures correlated to protection from severe dengue. Cell Host Microbe 33:1191\u20131207.e4","journal-title":"Cell Host Microbe"},{"key":"485_CR23","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S1473-3099(10)70166-3","volume":"10","author":"SB Halstead","year":"2010","unstructured":"Halstead SB, Mahalingam S, Marovich MA, Ubol S, Mosser DM (2010) Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis 10:712\u2013722","journal-title":"Lancet Infect Dis"},{"key":"485_CR24","doi-asserted-by":"publisher","first-page":"e01962","DOI":"10.1128\/jvi.01962-24","volume":"99","author":"CSC Hardy","year":"2025","unstructured":"Hardy CSC, Wegman AD, Waldran MJ, Chan GC, Waickman AT (2025) Conventional and antibody-enhanced DENV infection of human macrophages induces differential immunotranscriptomic profiles. J Virol 99:e01962\u201324","journal-title":"J Virol"},{"key":"485_CR25","doi-asserted-by":"publisher","first-page":"e0172358","DOI":"10.1371\/journal.pone.0172358","volume":"12","author":"A Jean","year":"2017","unstructured":"Jean A, Tardy F, Allatif O, Grosjean I, Blanquier B, Gerlier D (2017) Assessing mycoplasma contamination of cell cultures by qPCR using a set of universal primer pairs targeting a 1.5 kb fragment of 16S rRNA genes. PLoS ONE 12:e0172358","journal-title":"PLoS ONE"},{"key":"485_CR26","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aan6836","volume":"358","author":"LC Katzelnick","year":"2017","unstructured":"Katzelnick LC, Gresh L, Halloran ME, Mercado JC, Kuan G, Gordon A, Balmaseda A, Harris E (2017) Antibody-dependent enhancement of severe dengue disease in humans. Science 358:929\u2013932","journal-title":"Science"},{"key":"485_CR27","doi-asserted-by":"publisher","first-page":"6631","DOI":"10.1128\/JVI.00316-08","volume":"82","author":"C-Y Lai","year":"2008","unstructured":"Lai C-Y, Tsai W-Y, Lin S-R, Kao C-L, Hu H-P, King C-C, Wu H-C, Chang G-J, Wang W-K (2008) Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J. Virol. 82:6631\u20136643","journal-title":"J. Virol."},{"key":"485_CR28","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1086\/431520","volume":"192","author":"K Laoprasopwattana","year":"2005","unstructured":"Laoprasopwattana K, Libraty DH, Endy TP, Nisalak A, Chunsuttiwat S, Vaughn DW, Reed G, Ennis FA, Rothman AL, Green S (2005) Dengue Virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection. J Infect Dis 192:510\u2013519","journal-title":"J Infect Dis"},{"key":"485_CR29","doi-asserted-by":"publisher","first-page":"e00961","DOI":"10.1128\/msphere.00961-24","volume":"10","author":"S Lay","year":"2025","unstructured":"Lay S, Bohaud C, Sorn S, Ken S, Rey FA, Ari\u00ebn KK, Ly S, Duong V, Barba-Spaeth G, Auerswald H, Cantaert T (2025) Toward a deeper understanding of dengue: novel method for quantification and isolation of envelope protein epitope-specific antibodies. mSphere 10:e00961\u201324","journal-title":"mSphere"},{"key":"485_CR30","doi-asserted-by":"publisher","first-page":"6067","DOI":"10.1016\/j.cell.2021.11.009","volume":"184","author":"X-X Lim","year":"2021","unstructured":"Lim X-X, Shu B, Zhang S, Tan AWK, Ng T-S, Lim X-N, Chew VS-Y, Shi J, Screaton GR, Lok S-M, Anand GS (2021) Human antibody C10 neutralizes by diminishing Zika but enhancing dengue virus dynamics. Cell 184:6067\u20136080.e13","journal-title":"Cell"},{"key":"485_CR31","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/nsmb.1382","volume":"15","author":"S-M Lok","year":"2008","unstructured":"Lok S-M, Kostyuchenko V, Nybakken GE, Holdaway HA, Battisti AJ, Sukupolvi-Petty S, Sedlak D, Fremont DH, Chipman PR, Roehrig JT, Diamond MS, Kuhn RJ, Rossmann MG (2008) Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins. Nat Struct Mol Biol 15:312\u2013317","journal-title":"Nat Struct Mol Biol"},{"key":"485_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw9066","volume":"12","author":"S Maciejewski","year":"2020","unstructured":"Maciejewski S, Ruckwardt TJ, Morabito KM, Foreman BM, Burgomaster KE, Gordon DN, Pelc RS, DeMaso CR, Ko S-Y, Fisher BE, Yang ES, Nair D, Foulds KE, Todd JP, Kong W-P, Roy V, Aleshnick M, Speer SD, Bourne N, Barrett AD, Nason MC, Roederer M, Gaudinski MR, Chen GL, Dowd KA, Ledgerwood JE, Alter G, Mascola JR, Graham BS, Pierson TC (2020) Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality. Sci Transl Med 12:eaaw9066","journal-title":"Sci Transl Med"},{"key":"485_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2023.109883","volume":"587","author":"D Medina-Carrasco","year":"2023","unstructured":"Medina-Carrasco D, Pupo D, Gonz\u00e1lez-Lodeiro LG, Garc\u00eda LE, Martin AM, Huerta V (2023) Activity of domain III-specific antibodies in early convalescence: a case study. Virology 587:109883","journal-title":"Virology"},{"key":"485_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adq0571","volume":"17","author":"PI Mpingabo","year":"2025","unstructured":"Mpingabo PI, Ylade M, Aogo RA, Crisostomo MV, Thiono DJ, Daag JV, Agrupis K-A, Escoto AC, Raimundi-Rodriguez GL, Odio CD, Fernandez MA, White L, de Silva AM, Deen J, Katzelnick LC (2025) Protective envelope dimer epitope\u2013like antibodies are elicited against dengue virus in children after infection and vaccination. Sci Transl Med 17:eadq0571","journal-title":"Sci Transl Med"},{"key":"485_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-91099-5","volume":"15","author":"DA Muller","year":"2025","unstructured":"Muller DA, Choo JJY, McElnea C, Duyen HTL, Wills B, Young PR (2025) Kinetics of NS1 and anti-NS1 IgG following dengue infection reveals likely early formation of immune complexes in secondary infected patients. Sci Rep 15:6684","journal-title":"Sci Rep"},{"key":"485_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.580096","volume":"10","author":"R Narayan","year":"2020","unstructured":"Narayan R, Tripathi S (2020) Intrinsic ADE: the dark side of antibody dependent enhancement during dengue infection. Front Cell Infect Microbiol 10:580096","journal-title":"Front Cell Infect Microbiol"},{"key":"485_CR37","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev-immunol-042617-053142","volume":"36","author":"AE Ngono","year":"2018","unstructured":"Ngono AE, Shresta S (2018) Immune response to dengue and Zika. Annu Rev Immunol 36:279\u2013308","journal-title":"Annu Rev Immunol"},{"key":"485_CR38","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/infdis\/jit273","volume":"208","author":"S Olkowski","year":"2013","unstructured":"Olkowski S, Forshey BM, Morrison AC, Rocha C, Vilcarromero S, Halsey ES, Kochel TJ, Scott TW, Stoddard ST (2013) Reduced risk of disease during postsecondary dengue virus infections. J Infect Dis 208:1026\u20131033","journal-title":"J Infect Dis"},{"key":"485_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2020.113862","volume":"282","author":"TP Ou","year":"2020","unstructured":"Ou TP, Yun C, Auerswald H, In S, Leang R, Huy R, Choeung R, Dussart P, Duong V (2020) Improved detection of dengue and Zika viruses using multiplex RT-qPCR assays. J Virol Methods 282:113862","journal-title":"J Virol Methods"},{"key":"485_CR40","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0140-6736(23)02576-X","volume":"403","author":"G Paz-Bailey","year":"2024","unstructured":"Paz-Bailey G, Adams LE, Deen J, Anderson KB, Katzelnick LC (2024) Dengue. Lancet 403:667\u2013682","journal-title":"Lancet"},{"key":"485_CR41","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1128\/JVI.03203-15","volume":"90","author":"L Priyamvada","year":"2016","unstructured":"Priyamvada L, Cho A, Onlamoon N, Zheng N-Y, Huang M, Kovalenkov Y, Chokephaibulkit K, Angkasekwinai N, Pattanapanyasat K, Ahmed R, Wilson PC, Wrammert J (2016) B cell responses during secondary dengue virus infection are dominated by highly cross-reactive, memory-derived plasmablasts. J Virol 90:5574\u20135585","journal-title":"J Virol"},{"key":"485_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2017.42","volume":"6","author":"L Priyamvada","year":"2017","unstructured":"Priyamvada L, Hudson W, Ahmed R, Wrammert J (2017) Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology. Emerg Microbes Infect 6:e33","journal-title":"Emerg Microbes Infect"},{"key":"485_CR43","doi-asserted-by":"publisher","first-page":"e2274","DOI":"10.1371\/journal.pntd.0002274","volume":"7","author":"A Puschnik","year":"2013","unstructured":"Puschnik A, Lau L, Cromwell EA, Balmaseda A, Zompi S, Harris E (2013) Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans. PLoS Negl Trop Dis 7:e2274","journal-title":"PLoS Negl Trop Dis"},{"key":"485_CR44","doi-asserted-by":"publisher","first-page":"206","DOI":"10.15252\/embr.201745302","volume":"19","author":"FA Rey","year":"2018","unstructured":"Rey FA, Stiasny K, Vaney M-C, Dellarole M, Heinz FX (2018) The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design. EMBO Rep 19:206\u2013224","journal-title":"EMBO Rep"},{"key":"485_CR45","doi-asserted-by":"publisher","first-page":"e0012601","DOI":"10.1371\/journal.pntd.0012601","volume":"18","author":"C Roth","year":"2024","unstructured":"Roth C, Pitard B, Levillayer L, Lay S, Vo HTM, Cantaert T, Sakuntabhai A (2024) Zika virus T-cell based 704\/DNA vaccine promotes protection from Zika virus infection in the absence of neutralizing antibodies. PLoS Negl Trop Dis 18:e0012601","journal-title":"PLoS Negl Trop Dis"},{"key":"485_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15411","volume":"8","author":"A Rouvinski","year":"2017","unstructured":"Rouvinski A, Dejnirattisai W, Guardado-Calvo P, Vaney M-C, Sharma A, Duquerroy S, Supasa P, Wongwiwat W, Haouz A, Barba-Spaeth G, Mongkolsapaya J, Rey FA, Screaton GR (2017) Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope. Nat Commun 8:15411","journal-title":"Nat Commun"},{"key":"485_CR47","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature14130","volume":"520","author":"A Rouvinski","year":"2015","unstructured":"Rouvinski A, Guardado-Calvo P, Barba-Spaeth G, Duquerroy S, Vaney M-C, Kikuti CM, Navarro Sanchez ME, Dejnirattisai W, Wongwiwat W, Haouz A, Girard-Blanc C, Petres S, Shepard WE, Despr\u00e8s P, Arenzana-Seisdedos F, Dussart P, Mongkolsapaya J, Screaton GR, Rey FA (2015) Recognition determinants of broadly neutralizing human antibodies against dengue viruses. Nature 520:109\u2013113","journal-title":"Nature"},{"key":"485_CR48","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41586-018-0157-4","volume":"557","author":"H Salje","year":"2018","unstructured":"Salje H, Cummings DAT, Rodriguez-Barraquer I, Katzelnick LC, Lessler J, Klungthong C, Thaisomboonsuk B, Nisalak A, Weg A, Ellison D, Macareo L, Yoon I-K, Jarman R, Thomas S, Rothman AL, Endy T, Cauchemez S (2018) Reconstruction of antibody dynamics and infection histories to evaluate dengue risk. Nature 557:719\u2013723","journal-title":"Nature"},{"key":"485_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45806-x","volume":"15","author":"A Santos-Peral","year":"2024","unstructured":"Santos-Peral A, Luppa F, Goresch S, Nikolova E, Zaucha M, Lehmann L, Dahlstroem F, Karimzadeh H, Thorn-Seshold J, Winheim E, Schuster E-M, Dobler G, Hoelscher M, K\u00fcmmerer BM, Endres S, Schober K, Krug AB, Pritsch M, Barba-Spaeth G, Rothenfusser S (2024) Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection. Nat Commun 15:1696","journal-title":"Nat Commun"},{"key":"485_CR50","doi-asserted-by":"publisher","first-page":"6052","DOI":"10.1016\/j.cell.2021.11.010","volume":"184","author":"A Sharma","year":"2021","unstructured":"Sharma A, Zhang X, Dejnirattisai W, Dai X, Gong D, Wongwiwat W, Duquerroy S, Rouvinski A, Vaney M-C, Guardado-Calvo P, Haouz A, England P, Sun R, Zhou ZH, Mongkolsapaya J, Screaton GR, Rey FA (2021) The epitope arrangement on flavivirus particles contributes to Mab C10\u2019s extraordinary neutralization breadth across Zika and dengue viruses. Cell 184:6052\u20136066.e18","journal-title":"Cell"},{"key":"485_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.572681","volume":"10","author":"R Shukla","year":"2020","unstructured":"Shukla R, Ramasamy V, Shanmugam RK, Ahuja R, Khanna N (2020) Antibody-dependent enhancement: a challenge for developing a safe dengue vaccine. Front Cell Infect Microbiol 10:572681","journal-title":"Front Cell Infect Microbiol"},{"key":"485_CR52","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1128\/JVI.06335-11","volume":"86","author":"SA Smith","year":"2012","unstructured":"Smith SA, Zhou Y, Olivarez NP, Broadwater AH, de Silva AM, Crowe JE (2012) Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection. J Virol 86:2665\u20132675","journal-title":"J Virol"},{"key":"485_CR53","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ijmm.2008.08.002","volume":"299","author":"M St\u00f6rmer","year":"2009","unstructured":"St\u00f6rmer M, Vollmer T, Henrich B, Kleesiek K, Dreier J (2009) Broad-range real-time PCR assay for the rapid identification of cell-line contaminants and clinically important mollicute species. Int J Med Microbiol 299:291\u2013300","journal-title":"Int J Med Microbiol"},{"key":"485_CR54","doi-asserted-by":"publisher","first-page":"e01123","DOI":"10.1128\/mBio.01123-16","volume":"7","author":"JA Swanstrom","year":"2016","unstructured":"Swanstrom JA, Plante JA, Plante KS, Young EF, McGowan E, Gallichotte EN, Widman DG, Heise MT, de Silva AM, Baric RS (2016) Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against Zika virus. mBio 7:e01123\u201316","journal-title":"mBio"},{"key":"485_CR55","doi-asserted-by":"publisher","first-page":"e00745","DOI":"10.1128\/JVI.00745-20","volume":"94","author":"A Thomas","year":"2020","unstructured":"Thomas A, Thiono DJ, Kudlacek ST, Forsberg J, Premkumar L, Tian S, Kuhlman B, de Silva AM, Metz SW (2020) Dimerization of dengue virus E subunits impacts antibody function and domain focus. J Virol 94:e00745\u201320","journal-title":"J Virol"},{"key":"485_CR56","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1128\/CVI.00316-10","volume":"17","author":"S Ubol","year":"2010","unstructured":"Ubol S, Halstead SB (2010) How innate immune mechanisms contribute to antibody-enhanced viral infections. Clin Vaccine Immunol 17:1829\u20131835","journal-title":"Clin Vaccine Immunol"},{"key":"485_CR57","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/j.jinf.2014.07.020","volume":"69","author":"LM Verhagen","year":"2014","unstructured":"Verhagen LM, de Groot R (2014) Dengue in children. J Infect 69:S77\u2013S86","journal-title":"J Infect"},{"key":"485_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-21722-2","volume":"12","author":"HTM Vo","year":"2022","unstructured":"Vo HTM, Upasani V, Auerswald H, Lay S, Sann S, Vanderlinden A, Ken S, Sorn S, Ly S, Duong V, Dussart P, Cantaert T (2022) Temporal patterns of functional anti-dengue antibodies in dengue infected individuals with different disease outcome or infection history. Sci Rep 12:17863","journal-title":"Sci Rep"},{"key":"485_CR59","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1128\/JCM.01359-13","volume":"51","author":"JJ Waggoner","year":"2013","unstructured":"Waggoner JJ, Abeynayake J, Sahoo MK, Gresh L, Tellez Y, Gonzalez K, Ballesteros G, Guo FP, Balmaseda A, Karunaratne K, Harris E, Pinsky BA (2013) Comparison of the FDA-approved CDC DENV-1-4 real-time reverse transcription-PCR with a laboratory-developed assay for dengue virus detection and serotyping. J Clin Microbiol 51:3418\u20133420","journal-title":"J Clin Microbiol"},{"key":"485_CR60","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.virol.2009.06.037","volume":"392","author":"WMPB Wahala","year":"2009","unstructured":"Wahala WMPB, Kraus AA, Haymore LB, Accavitti-Loper MA, de Silva AM (2009) Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody. Virology 392:103\u2013113","journal-title":"Virology"},{"key":"485_CR61","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adk3259","volume":"16","author":"L Wang","year":"2024","unstructured":"Wang L, Huang AT, Katzelnick LC, Lefrancq N, Escoto AC, Duret L, Chowdhury N, Jarman R, Conte MA, Berry IM, Fernandez S, Klungthong C, Thaisomboonsuk B, Suntarattiwong P, Vandepitte W, Whitehead SS, Cauchemez S, Cummings DAT, Salje H (2024) Antigenic distance between primary and secondary dengue infections correlates with disease risk. Sci Transl Med 16:eadk3259","journal-title":"Sci Transl Med"},{"key":"485_CR17","unstructured":"WHO (2009) Dengue: guidelines for diagnosis, treatment, prevention and control. World Health Organization"},{"key":"485_CR62","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.immuni.2020.09.001","volume":"53","author":"R Wong","year":"2020","unstructured":"Wong R, Belk JA, Govero J, Uhrlaub JL, Reinartz D, Zhao H, Errico JM, D\u2019Souza L, Ripperger TJ, Nikolich-Zugich J, Shlomchik MJ, Satpathy AT, Fremont DH, Diamond MS, Bhattacharya D (2020) Affinity-restricted memory B cells dominate recall responses to heterologous flaviviruses. Immunity 53:1078\u20131094.e7","journal-title":"Immunity"},{"key":"485_CR63","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/s41564-023-01421-y","volume":"8","author":"R Yamin","year":"2023","unstructured":"Yamin R, Kao KS, MacDonald MR, Cantaert T, Rice CM, Ravetch JV, Bournazos S (2023) Human Fc\u03b3RIIIa activation on splenic macrophages drives dengue pathogenesis in mice. Nat Microbiol 8:1468\u20131479","journal-title":"Nat Microbiol"},{"key":"485_CR64","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.chom.2020.04.007","volume":"27","author":"E Young","year":"2020","unstructured":"Young E, Carnahan RH, Andrade DV, Kose N, Nargi RS, Fritch EJ, Munt JE, Doyle MP, White L, Baric TJ, Stoops M, DeSilva A, Tse LV, Martinez DR, Zhu D, Metz S, Wong MP, Espinosa DA, Montoya M, Biering SB, Sukulpolvi-Petty S, Kuan G, Balmaseda A, Diamond MS, Harris E, Crowe JE, Baric RS (2020) Identification of dengue virus serotype 3 specific antigenic sites targeted by neutralizing human antibodies. Cell Host Microbe 27:710\u2013724.e7","journal-title":"Cell Host Microbe"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00485-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00485-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00485-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:31:46Z","timestamp":1789021906000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00485-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":64,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,10]]}},"alternative-id":["485"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00485-7","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}